Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.

MLA

Mimura, Wataru, et al. “Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.” Journal of Epidemiology, vol. 34, no. 6, June 2024, pp. 278–85. EBSCOhost, https://doi.org/10.2188/jea.JE20230106.

APA

Mimura, W., Ishiguro, C., Terada-Hirashima, J., Matsunaga, N., Sato, S., Kawazoe, Y., Maeda, M., Murata, F., & Fukuda, H. (2024). Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study. Journal of Epidemiology, 34(6), 278–285. https://doi.org/10.2188/jea.JE20230106

Chicago

Mimura, Wataru, Chieko Ishiguro, Junko Terada-Hirashima, Nobuaki Matsunaga, Shuntaro Sato, Yurika Kawazoe, Megumi Maeda, Fumiko Murata, and Haruhisa Fukuda. 2024. “Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.” Journal of Epidemiology 34 (6): 278–85. doi:10.2188/jea.JE20230106.